Drawing for CELEXION

USPTO serial 77810609

CELEXION

Reviewed by CopyMark Law Group

Reg. 4392501Status 710
Filing date
Status date
Registration date
Aug 27, 2013
Examiner
FRUM MILONE, MARCIE R
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CELEXION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph A. Capraro, Jr.

Joseph A. Capraro, Jr. PROSKAUER ROSE LLP1 INTERNATIONAL PL FL 22BOSTON, MA 02110-2639UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, polypeptides for in vitro research use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; chemicals, namely, peptides and proteins for use in the manufacture of pharmaceuticals and chemical intermediates or for use in scientific and medical research; peptides or proteins for laboratory or research use, namely, for use in drug discovery, generation, and screening; * all the aforementioned goods in this class not for sale to or by pharmacies *SECTION 8 - CANCELLED—
005Pharmaceutical preparations, namely, peptides and proteins for use in the prevention, diagnosis and treatment of cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; chemicals, namely, peptides and proteins for medical diagnostic purposes; * all the aforementioned goods in this class not for sale to pharmacies and individual consumers *SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2020C8..CANCELLED SEC. 8 (6-YR)—
Aug 27, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 1, 2013A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Oct 29, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 22, 2013AMD7SEC 7 REQUEST FILED—
Oct 22, 2013ES7RTEAS SECTION 7 REQUEST RECEIVED—
Aug 27, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2013SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 19, 2013REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jul 18, 2013CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 26, 2013SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 20, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 23, 2013IUAFUSE AMENDMENT FILED—
May 23, 2013EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 16, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2012EX5GSOU EXTENSION 5 GRANTED—
Nov 12, 2012EXT5SOU EXTENSION 5 FILED—
Nov 12, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 12, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 11, 2012EX4GSOU EXTENSION 4 GRANTED—
May 23, 2012EXT4SOU EXTENSION 4 FILED—
May 23, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 28, 2011EX3GSOU EXTENSION 3 GRANTED—
Nov 22, 2011EXT3SOU EXTENSION 3 FILED—
Nov 22, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 24, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 21, 2011EX2GSOU EXTENSION 2 GRANTED—
May 20, 2011EXT2SOU EXTENSION 2 FILED—
May 20, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 10, 2011EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 22, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2010NOACCORRECTED NOA E-MAILED—
Dec 21, 2010EX1GSOU EXTENSION 1 GRANTED—
Dec 21, 2010DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 16, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 24, 2010DRRRDIVISIONAL REQUEST RECEIVED—
Nov 24, 2010ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 23, 2010EXT1SOU EXTENSION 1 FILED—
Nov 23, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 25, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 2, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 2, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 26, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 22, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jan 22, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 22, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 22, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 15, 2010ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 28, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 14, 2009ALIEASSIGNED TO LIE—
Nov 30, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Nov 30, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 30, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 30, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 24, 2009DOCKASSIGNED TO EXAMINER—
Aug 25, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance